Non-coding transcript in T cells (NTT): Antisense transcript activates PKR and NF-κB in human lymphocytes

Blood Cells, Molecules, and Diseases

Volumn 40, Issue 2, 2008, Pages 227-232

  Delgado André, Nayara ^a   De Lucca, Fernando L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antisense NTT; Lymphocyte activation; NF B; Non coding RNAs (ncRNAs); Non coding T cell transcript (NTT); PKR

Indexed keywords

I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE R;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EIF-2 KINASE; ENZYME ACTIVATION; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; NF-KAPPA B; PEPTIDES; PHOSPHORYLATION; RNA, ANTISENSE; RNA, UNTRANSLATED; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 38949084873     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.08.005     Document Type: Article

References (30)

1. Erdmann V.A., Barciszewska M.Z., Hochberg A., de Groot N., and Barciszewski J. Regulatory RNAs. Cell Mol. Life Sci. 58 (2001) 960-977
2. Erdmann V.A., Barciszewska M.Z., Szymanski M., Hochberg A., de Groot N., and Barciszewski J. The non-coding RNAs as riboregulators. Nucleic Acids Res. 29 (2001) 189-193
3. Hüttenhofer A., Schattner P., and Polacek N. Non-coding RNAs: hope or hype?. Trends Genet. 21 (2005) 289-297
4. Storz G., Altuvia S., and Wassarman K.M. An abundance of RNA regulators. Annu. Rev. Biochem. 74 (2005) 199-217
5. Szymanski M., Barciszewska M.Z., Erdmann V.A., and Barciszewski J. A new frontier for molecular medicine: noncoding RNAs. Biochim. Biophys. Acta 1756 (2005) 65-75
6. Mattick J.S., and Makunin I.V. Non-coding RNA. Hum. Mol. Genet. 15 (2006) R17-R29
7. + T cells. Genomics 39 (1997) 171-174
8. Amarante M.K., De Lucca F.L., de Oliveira C.E.C., Fungaro M.H.P., Reiche E.M.V., Muxel S.M., and Watanabe M.A.E. Expression of non-coding mRNA in human blood cells activated with synthetic peptide of HIV. Blood Cells Mol. Dis. 35 (2005) 286-290
9. Murad J.M., Souza L.R., and De Lucca F.L. PKR activation by a non-coding RNA expressed in lymphocytes of mice bearing B16 melanoma. Blood Cells Mol. Dis. 37 (2006) 128-133
10. Clemens M.J., and Elia A. The double-stranded RNA-dependent protein kinase: structure and function. J. Interferon Cytokine Res. 17 (1997) 503-524
11. Watanabe M.A.E., Souza L.R., Murad J.M., and De Lucca F.L. Activation of the RNA-dependent protein kinase of lymphocytes by regulatory RNAs: implications for immunomodulation in HIV infection. Curr. HIV Res. 3 (2005) 329-337
12. García M.A., Gil J., Ventoso I., Guerra S., Domingo E., Rivas C., and Esteban M. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70 (2006) 1032-1060
13. Gil J., Alcami J., and Esteban M. Activation of NF-kappaB by the dsRNA-dependent protein kinase, PKR involves the I-kappa B kinase complex. Oncogene 19 (2000) 1369-1378
14. Karin M., and Neriah Y.B. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
15. Ribeiro R.A., De Lucca F.L., Flores C.A., Cunha F.Q., and Ferreira S.H. RNA from LPS-stimulated macrophages induces the release of tumor necrosis factor-α and interleukin-1 by resident macrophages. Med. Inflammation 2 (1993) 435-442
16. Ribeiro R.A., De Lucca F.L., Flores C.A., Cunha F.Q., and Ferreira S.H. Partial characterization of the RNA from LPS-stimulated macrophages that induces the release of chemotactic cytokines by resident macrophages. Mol. Cell. Biochem. 20 (1995) 105-113
17. De Lucca F.L., Serrano S.V., Souza L.R., and Watanabe M.A.E. Activation of RNA-dependent protein kinase and nuclear factor-κB by regulatory RNA from lipopolysaccharide-stimulated macrophages: implications for cytokine production. Eur. J. Pharmacol. 450 (2002) 85-89
18. Watanabe M.A.E., Souza L.R., Murad J.M., and De Lucca F.L. Anti-tumor activity induced by regulatory RNA: possible role of RNA-dependent protein kinase and nuclear factor-κB. Eur. J. Pharmacol. 465 (2003) 205-210
19. De Lucca F.L., Sales V.S.F., Souza L.R., Murad J.M., and Watanabe M.A.E. Regulatory RNA induces the production of IFN-γ, but not IL-4 in human lymphocytes: role of RNA-dependent protein kinase (PKR) and NF-κB. Mol. Cell. Biochem. 247 (2003) 211-217
20. Bommer U., Borovjagin A.V., Greagg M.A., Jeffrey I.W., Russell P., Laing K.G., Lee M., and Clemens M.J. The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR. RNA 8 (2002) 478-496
21. Murad J.M., Tone L.G., de Souza L.R., and De Lucca F.L. A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia. Blood Cells Mol. Dis. 34 (2005) 1-5
22. Lehner B., Williams G., Campbell R.D., and Sanderson C.M. Antisense transcripts in the human genome. Trends Genet. 18 (2002) 63-65
23. Yelin R., Dahary D., Sorek R., Levanon E.Y., Goldstein O., Shoshan A., Diber A., Biton S., Tamir Y., Khosravi R., Nemzer S., Pinner E., Walach S., Bernstein J., Savitsky K., and Rotman G. Widespread occurrence of antisense transcription in the human genome. Nat. Biotechnol. 21 (2003) 379-386
24. Yan M.D., Hong C.C., Lai G.M., Cheng A.L., and Lin Y.W. Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas. Hum. Mol. Genet. 14 (2005) 1465-1474
25. Lavorgna G., Dahary D., Lehner B., Sorek R., Sanderson C.M., and Casari G. In search of antisense. Trends Biochem. Sci. 29 (2004) 88-94
26. Munroe S.H. Diversity of antisense regulation in eukaryotes: multiple mechanisms, emerging patterns. J. Cell. Biochem. 93 (2004) 664-671
27. Neeman Y., Dahary D., Levanon E.Y., Sorek R., and Eisenberg E. Is there any sense in antisense editing?. Trends Genet. 21 (2005) 544-547
28. Hayden M.S., West A.P., and Ghosh S. NF-κB and the immune response. Oncogene 25 (2006) 6758-6780
29. Thompson J.E., Phillips R.J., Erdjument-Bromage H., Tempst P., and Ghosh S. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80 (1995) 573-582
30. Ravi R., and Bedi A. NF-kappaB in cancer - a friend turned foe. Drug Resist. Updat. 7 (2004) 53-67